What is the recommended dose of amoxicillin (amoxicillin) for treating pneumonia in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Dosing for Pneumonia in Adults

For community-acquired pneumonia in adults, amoxicillin should be dosed at 1 gram orally every 8 hours (3 grams total daily), not the lower standard doses of 250-500 mg three times daily. 1

Outpatient Treatment Regimens

Otherwise Healthy Adults (No Comorbidities)

  • Amoxicillin 1 g orally every 8 hours as monotherapy is the recommended regimen for previously healthy adults with community-acquired pneumonia 1, 2
  • This high-dose regimen provides adequate coverage even against drug-resistant Streptococcus pneumoniae (DRSP) despite lacking activity against atypical organisms 1
  • The FDA-approved adult dosing range is 750 to 1750 mg/day in divided doses every 8 to 12 hours 3

Adults with Comorbidities

  • For patients with comorbidities (cardiopulmonary disease, diabetes, chronic kidney/liver disease, immunosuppression, or age ≥65 years), amoxicillin 1 g every 8 hours must be combined with a macrolide (azithromycin 500 mg daily or clarithromycin 500 mg twice daily) 1, 2
  • This combination addresses the risk of mixed infections with atypical organisms (Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella) which are common in this population 1

Alternative Beta-Lactam Option

  • Amoxicillin-clavulanate 2000/125 mg twice daily can substitute for amoxicillin when beta-lactamase-producing organisms (H. influenzae, M. catarrhalis) are suspected 1
  • This formulation provides enhanced coverage while maintaining the high amoxicillin dose needed for pneumococcal coverage 1

Hospitalized Patients (Non-Severe)

  • For non-severe inpatients, use a beta-lactam plus macrolide combination: ampicillin-sulbactam 1.5-3 g every 6 hours, cefotaxime 1-2 g every 8 hours, or ceftriaxone 1-2 g daily PLUS azithromycin 500 mg daily or clarithromycin 500 mg twice daily 4
  • Note that amoxicillin oral formulation is typically not the preferred beta-lactam for hospitalized patients requiring parenteral therapy 4

Treatment Duration

  • Treat for 5-7 days in patients demonstrating clinical improvement 1
  • Treatment should not routinely exceed 8 days in responding patients 1
  • For severe pneumonia without identified pathogens, extend duration to 10 days 2

Critical Dosing Pitfalls to Avoid

Underdosing Risk

  • Never use standard-dose amoxicillin (250-500 mg three times daily) for pneumonia, as this underdosing increases treatment failure risk and promotes antimicrobial resistance 1
  • The high-dose regimen (1 g every 8 hours) is essential for achieving adequate serum and tissue concentrations against pneumococcal strains 5

Inappropriate Monotherapy

  • Amoxicillin monotherapy should not be used in patients with comorbidities without adding atypical coverage, as mixed infections are common in this population 1
  • Macrolide monotherapy should be avoided in areas with pneumococcal macrolide resistance ≥25%, but amoxicillin remains effective 1, 2

Recent Antibiotic Exposure

  • Switch to a different antibiotic class if the patient received amoxicillin within the past 3 months to reduce resistance risk 1, 2
  • This applies to any recent beta-lactam exposure, not just amoxicillin specifically 2

Contraindications and Limitations

  • Amoxicillin should not be used for suspected MRSA or Pseudomonas aeruginosa pneumonia, as these require alternative coverage 1
  • History of serious hypersensitivity reactions (anaphylaxis, Stevens-Johnson syndrome) to amoxicillin or other beta-lactams is an absolute contraindication 3
  • For patients not improving on initial amoxicillin therapy, add or substitute a macrolide to cover atypical pathogens 2

Dose Adjustment in Renal Impairment

  • Reduce the dose in patients with severe renal impairment (GFR <30 mL/min) 3
  • The FDA label recommends dose reduction in elderly patients and those with renal failure, though specific adjustments for oral amoxicillin in pneumonia are not precisely defined in the guidelines 3

References

Guideline

Amoxicillin Dosing for Community-Acquired Pneumonia in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Community-Acquired Pneumonia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.